The Clinton Global Initiative honored the Abundance Foundation at its annual meeting on Sept. 27 for the organization’s innovative Ebola test, developed by its Abundance Project for Global Health to quickly and easily diagnose the disease.
The test, called the Corgenix Ebola test, is simple to use and interpret
and does not require electricity, allowing those on the ground to
quickly identify those infected with the disease so that they can be
separated from family members and treated.
"Working alongside healthcare providers on the frontline of the Ebola crisis, Dr. Megan Murray's team conducted rigorous scientific research that proved the exceptional accuracy of a diagnostic tool that is as easy to use as a pregnancy test," Dr. Stephen Kahn, President of the Abundance Foundation, said. "This is a crucial tool to avoid a two-day delay in diagnosis. During this two day gap, family members are exposed to Ebola, contact tracing becomes more difficult, and life-saving treatments for Ebola and other diseases are delayed."
The Abundance Foundation began in 2010 as a CGI Commitment to Action project and has since worked for the betterment of medical education and health systems in in Haiti and Rwanda in an effort to prevent the spread of disease.
"The Abundance Foundation is a small, nimble philanthropic catalyst for global health systems change," said Dr. Kahn. "We come to CGI to share our impact, and to invite partners to join in taking this success to scale."